Keywords: athena, launch, zanaflex, uk, elan, corp, wholly-owned

Athena To Launch Zanaflex in UK

Article | 11 September 1997

- Elan Corp's wholly-owned subsidiary Athena Neurosciences is tolaunch its spasticity treatment Zanaflex (tizanidine HCl) in the UK in October. Zanaflex ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Tizanidine

Zanaflex

Nystatin

Go to drug listing